Pentair vs Xylem
PNR and XYL side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PNR and XYL compare
Xylem is the larger company, worth 2.0 times as much as Pentair ($21.6B against $10.6B).
On earnings, Pentair is cheaper: it trades at 16.6× trailing earnings, against 22.0× for Xylem.
Xylem grew revenue faster over the last twelve months (4.5% versus −2.1% for Pentair).
Pentair keeps more of each dollar of sales as profit, with a net margin of 16.2% compared with 11.2% at Xylem.
Both pay dividends: Pentair yields 1.2% and Xylem 1.8%.
Xylem scores higher on the StockData Score (23 against 18 for Pentair), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PNR | XYL |
|---|---|---|
| Size and price | ||
| Market cap | $10.6B | $21.6B |
| Share price | $66.26 | $92.40 |
| Change, 1 year | −38.4% | −39.6% |
| Change, 5 years | −10.8% | −29.5% |
| Beta (5Y) | 1.15 | 0.99 |
| Employees | 9,000 | 22K |
| StockData Score | ||
| Total score | 18 | 23 (better) |
| Valuation score | 6 | 6 |
| Growth score | 3 | 4 (better) |
| Performance score | 3 | 3 |
| Health score | 3 | 6 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 16.6× (better) | 22.0× |
| P/S | 2.6× | 2.4× (better) |
| P/B | – | 2.1× |
| EV/EBITDA | 14.9× (better) | 17.6× |
| P/FCF | 15.7× (better) | 22.5× |
| PEG | 1.52 | 0.85 (better) |
| FCF yield | 6.4% (better) | 4.4% |
| Fair value | $85.88 | $129.28 |
| Margin of safety | 22.8% | 28.5% (better) |
| Growth | ||
| Revenue growth (TTM) | −2.1% | 4.5% (better) |
| Revenue growth, 5Y average | 6.7% | 13.1% (better) |
| Net income growth (TTM) | 6.9% | 8.5% (better) |
| EPS growth (TTM) | 8.4% | 9.1% (better) |
| EPS growth, 5Y average | 13.1% | 22.9% (better) |
| Profitability | ||
| Gross margin | 41.3% (better) | 39.2% |
| Operating margin | 20.3% (better) | 14.5% |
| Net margin | 16.2% (better) | 11.2% |
| FCF margin | 16.8% (better) | 10.5% |
| Return on equity | – | 9.5% |
| Return on invested capital | – | 8.7% |
| Financial health | ||
| Debt / equity | – | 0.28 |
| Net debt / EBITDA | 1.86 | 1.25 (better) |
| Interest coverage | – | 57.4× |
| Current ratio | 1.45 | 1.61 (better) |
| Altman Z-score | 3.85 (better) | 3.15 |
| Piotroski F-score | 9 (better) | 7 |
| Dividends and buybacks | ||
| Dividend yield | 1.2% | 1.8% (better) |
| Payout ratio | 26.0% | 39.5% |
| Years of dividend growth | 6 | 13 (better) |
| Dividend growth, 5Y average | 5.6% | 9.0% (better) |
| Buyback yield | 4.2% | 5.8% (better) |
| Shareholder yield | 5.5% | 7.6% (better) |
| Ownership | ||
| Held by institutions | 95.8% | 93.2% |
| Held by insiders | 0.81% | 0.19% |
| Insider net buying, 12 months | −$2.9M | −$612K (better) |
| Short interest, % of float | 4.7% | 4.5% |
Go deeper
- PNR stock overview
- PNR income statement
- PNR valuation and score
- XYL stock overview
- XYL income statement
- XYL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.